Aparicio, Thomas http://orcid.org/0000-0001-8834-6927
Cozic, Nathalie
de la Fouchardière, Christelle
Meriaux, Emeline
Plaza, Jérome
Mineur, Laurent
Guimbaud, Rosine
Samalin, Emmanuelle
Mary, Florence
Lecomte, Thierry
Gomez-Roca, Carlos
Haineaux, Paul-Arthur
Gratet, Alain
Selves, Jannick
Menu, Yves
Colignon, Nikias
Johnson, Laetitia
Legrand, Frédéric
Vassal, Gilles
Funding for this research was provided by:
Institut National Du Cancer
Fondation ARC pour la Recherche sur le Cancer
Article History
Accepted: 20 March 2021
First Online: 13 April 2021
Declarations
:
: This program was founded by the French National Cancer Institute (INCa), the ARC Foundation for Cancer Research, and Unicancer’s personalized medicine research partners. This work was institutionally supported by Pfizer. No grant number is applicable.
: T. Aparicio has received honorarium from Roche, Ipsen, Amgen, Servier, Sanofi, and Bioven. L. Mineur has received honorarium from Merck, Servier, and Pierre Fabre and has received research grants from Amgen and Sanofi. R. Guimbaud has received honorarium from AAA, AstraZeneca, Amgen, BMS, Pierre Fabre, Novartis, Roche, and Servier. E. Samalin has received honorarium from Roche, Servier, Sanofi, MSD, BMS, Amgen, and Pierre Fabre. T. Lecomte has received honorarium from Ipsen, Amgen, Merck, Sanofi, Servier, Bayer, and Novartis. CA. Gomez-Roca has received honorarium from BMS, Roche, Pierre Fabre, Eisai, and Foundation Medicine, and has received research grants from Roche and BMS. G. Vassal has received honorarium from Bayer, Boehringer-Ingelheim, BMS, Celgene, Exelixis, Incyte Biosciences, Lilly, Merck, Novartis, Pfizer, Roche/Genentech, Servier and Takeda. N. Cozic, C. De La Fouchardière, E. Meriaux r, J. Plaza, F. Mary, PA. Haineaux, A. Gratet, J. Selves, Y. Menu, N. Colignon, L. Johnson, and F. Legrand declare that they have no conflicts of interest that might be relevant to the contents of this article.
: The study was approved by the ethics committee (13 May 2013 by CPP Ile De France VII Kremlin Bicêtre, protocol 2013-000885-13)
: Data are available from the corresponding author upon reasonable request.
: Study design: TA, NCoz, GV. Data acquisition: TA, CF, EM, JP, LM, RG, ES, FM, TL, CAGR, PAH, AG, JS, YM, NCol, FL. Statistical analysis: NCoz. Manuscript preparation: TA, NCoz, LI. Manuscript review: all authors.
: Not applicable.
: Not applicable.